|[December 18, 2012]
Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference
AMSTERDAM --(Business Wire)--
Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on
providing surgical solutions to orthopaedic extremity specialists,
announced today that David Mowry, the Company's Interim President and
Chief Executive Officer, and Shawn McCormick, the Company's Chief
Financial Officer, will be presenting at the 31st Annual J.P.
Morgan Healthcare Conference.
The Company's presentation is scheduled for Monday, January 7, at 11:30
a.m. pacific time at the Westin St. Francis Hotel in San Francisco, CA (News - Alert).
The presentation will be webcast live on the Investor Relations section
of the Company's website at www.tornier.com.
For those who are not available to listen to the live webcast, a replay
will be archived for one year.
Tornier is a global medical device company focused on serving
extremities specialists who treat orthopaedic conditions of the
shoulder, elbow, wrist, hand, ankle and foot. The Company's broad
offering of over 100 product lines includes joint replacement, trauma,
sports medicine, and ortho-biologic products through Tornier and
OrthoHelix brands to treat the extremities, as well as joint replacement
products for the hip and knee in certain international markets. Since
its founding approximately 70 years ago, Tornier's "Specialists Serving
Specialists" philosophy has fostered a tradition of innovation, intense
focus on surgeon education, and commitment to advancement of orthopaedic
technology stemming from its close collaboration with orthopaedic
surgeons and thought leaders throughout the world. For more information
regarding Tornier, visit www.tornier.com,
or OrthoHelix, visit www.orthohelix.com.
[ Back To TMCnet.com's Homepage ]